- Report
- October 2024
- 184 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Cyclandelate is a cardiovascular drug used to treat peripheral vascular disease, a condition in which the blood vessels in the legs become narrowed and hardened. It works by dilating the blood vessels, allowing more blood to flow through them and reducing the symptoms of the disease. Cyclandelate is available in both oral and topical forms, and is often used in combination with other medications to treat the condition.
Cyclandelate is a widely used drug in the cardiovascular market, with many pharmaceutical companies producing and marketing it. Some of the major companies in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more